A NEW promising approach to treat Leukemia was recently discovered – an overview of the research article by BIOMEDICA CRO 🔬

In a recent study, researchers at Peter MacCallum Cancer Centre have unveiled a promising new approach to treating Acute Myeloid Leukemia (AML). By leveraging a combination of measurable residual disease (MRD) technology, medication, and low-dose chemotherapy, the research team has achieved remarkable results in halting the progression of the disease and extending remission periods.

“This is a paradigm-changing clinical trial that utilizes molecular technologies to enable patients to receive their interventional therapy much earlier than normal and with less toxicity,” said Professor Andrew Wei, co-lead of the AML program.

Please find more information about this research on the Peter MacCallum Cancer Centre website.

In light of these developments, we at BIOMEDICA CRO want to highlight our readiness to assist with studies in the field of hematology malignancies by providing high-quality human bone marrow and blood specimens & associated clinical data from individuals with various Hematology malignancy conditions.

Bone marrow, blood and other biospecimens collection by BIOMEDICA CRO from subjects with hematology malignancy🩸

BIOMEDICA CRO has been a global provider of various human biological samples since 2017. We offer prospective and retrospective collections of various human biospecimen types and associated clinical data.
Our own network of 50+ direct contracts with hospitals in Ukraine allows us to participate in the research of a wide range of diseases. We can provide support for the following projects focused on hematological disorders research:

Multiple Myeloma;
Myelodysplastic Syndrome;
Diffuse Large B-cell Lymphoma (DLBCL);
Acute Myeloid Leukemia (AML);
Chronic Myeloid Leukemia (CML);
Acute Lymphocytic Leukemia (ALL);
Chronic Lymphocytic Leukemia (CLL);
Other Hodgkin’s and non-Hodgkin’s Lymphomas, and more.

In our standard collection process, we can procure up to 40-50 ml of whole blood from each donor, which can then be processed into various biosample types such as plasma, buffy coat, serum, PBMC, and others. Additionally, we can provide bone marrow trephine aspirate in FFPE blocks or fresh frozen bone marrow aspirate for some indications. Thus, our Customers have an opportunity to order matched sets of different blood and bone marrow samples.

Furthermore, we provide comprehensive clinical data for each case alongside biosamples, including general donor information, diagnostic methodologies, laboratory test results, and relevant additional details. This detailed sample and donor data can be provided using our standard Data Manifest templates or your preferred format, including eCRFs, Google forms, or other specified templates.

At BIOMEDICA CRO, we are fully committed to meeting the specific Inclusion and Exclusion criteria outlined by our Customers, as well as adhering to customized sample processing and aliquoting schemes to ensure the highest quality standards for your research endeavors.

📩 Please email us to start our collaboration and order biospecimens at office@biomedica-cro.com.
BIOMEDICA CRO team is fully committed to supporting you in every step of your journey. We would be delighted to discuss your project in detail, address any inquiries you may have, and tailor our support to meet your research goals.

🌐 Clicking here, you can explore our extensive range of banked biological samples.

🚀 Follow us on LinkedIn to stay up-to-date with the latest advancements, industry news, and exclusive offers in the field of human biospecimen procurement. Together, let’s drive innovation and make remarkable discoveries.